Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q3 EPS of ($0.24), $0.03 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.